Global PNH and aHUS Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global PNH and aHUS market size was valued at US$ 2121 million in 2025 and is forecast to a readjusted size of US$ 2491 million by 2032 with a CAGR of 2.3% during review period.
PNH and aHUS, both are extremely rare and genetic diseases. Due to PNH, destruction of red blood cells of a person occurs quite sooner than it should. It is an acquired hematopoietic stem cell disorder. Hematopoietic stem cells are developed in bone marrow and eventually turn into red blood cells, white blood cells and platelets. A person with PNH has some defected hematopoietic cells which create defective red blood cells. These defective cells are highly susceptible to premature destruction by the complement system. aHUS is a disorders in which blood clots are formed in small blood vessels throughout the body. TMA can lead to heart stroke, attack, kidney failure and death.
The market for Paroxysmal Nocturnal Hemoglobinuria (PNH) and Atypical Hemolytic Uremic Syndrome (aHUS) is primarily driven by increased awareness and improved diagnostic capabilities for these rare, life-threatening hematologic and renal disorders. Advances in molecular biology and genetic testing have enabled earlier and more accurate diagnosis, leading to timely treatment initiation, which significantly improves patient outcomes. Furthermore, the introduction and approval of novel targeted therapies, such as complement inhibitors (e.g., eculizumab and ravulizumab), have revolutionized the treatment landscape by offering effective disease management options that reduce hemolysis, thrombotic events, and organ damage. Growing investment in research and development, coupled with supportive regulatory frameworks and orphan drug designations, also accelerates the availability of innovative therapies. Additionally, increasing patient advocacy and education programs have raised disease recognition among healthcare professionals, contributing to market growth.
Despite the promising growth prospects, the PNH and aHUS market faces several challenges that limit broader access and adoption of therapies. One significant barrier is the high cost of treatment, especially with complement inhibitors, which can impose substantial financial burdens on healthcare systems and patients, particularly in low- and middle-income countries. This cost factor often restricts widespread accessibility and reimbursement, limiting patient access to life-saving drugs. Moreover, the rarity of these diseases results in a small patient population, which poses challenges for conducting large-scale clinical trials and hinders extensive data generation for long-term safety and efficacy. Another challenge is the complexity of disease diagnosis due to overlapping symptoms with other hematological or renal conditions, sometimes causing delayed or missed diagnosis. Lastly, the need for lifelong treatment in many cases raises concerns about patient adherence, potential side effects, and the development of resistance, necessitating continuous monitoring and management strategies.
This report is a detailed and comprehensive analysis for global PNH and aHUS market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global PNH and aHUS market size and forecasts, in consumption value ($ Million), 2021-2032
Global PNH and aHUS market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global PNH and aHUS market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global PNH and aHUS market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for PNH and aHUS
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global PNH and aHUS market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZeneca, Alexion Pharmaceutical, CJSC Generium, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
PNH and aHUS market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe PNH and aHUS product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of PNH and aHUS, with revenue, gross margin, and global market share of PNH and aHUS from 2021 to 2026.
Chapter 3, the PNH and aHUS competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and PNH and aHUS market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of PNH and aHUS.
Chapter 13, to describe PNH and aHUS research findings and conclusion.
PNH and aHUS, both are extremely rare and genetic diseases. Due to PNH, destruction of red blood cells of a person occurs quite sooner than it should. It is an acquired hematopoietic stem cell disorder. Hematopoietic stem cells are developed in bone marrow and eventually turn into red blood cells, white blood cells and platelets. A person with PNH has some defected hematopoietic cells which create defective red blood cells. These defective cells are highly susceptible to premature destruction by the complement system. aHUS is a disorders in which blood clots are formed in small blood vessels throughout the body. TMA can lead to heart stroke, attack, kidney failure and death.
The market for Paroxysmal Nocturnal Hemoglobinuria (PNH) and Atypical Hemolytic Uremic Syndrome (aHUS) is primarily driven by increased awareness and improved diagnostic capabilities for these rare, life-threatening hematologic and renal disorders. Advances in molecular biology and genetic testing have enabled earlier and more accurate diagnosis, leading to timely treatment initiation, which significantly improves patient outcomes. Furthermore, the introduction and approval of novel targeted therapies, such as complement inhibitors (e.g., eculizumab and ravulizumab), have revolutionized the treatment landscape by offering effective disease management options that reduce hemolysis, thrombotic events, and organ damage. Growing investment in research and development, coupled with supportive regulatory frameworks and orphan drug designations, also accelerates the availability of innovative therapies. Additionally, increasing patient advocacy and education programs have raised disease recognition among healthcare professionals, contributing to market growth.
Despite the promising growth prospects, the PNH and aHUS market faces several challenges that limit broader access and adoption of therapies. One significant barrier is the high cost of treatment, especially with complement inhibitors, which can impose substantial financial burdens on healthcare systems and patients, particularly in low- and middle-income countries. This cost factor often restricts widespread accessibility and reimbursement, limiting patient access to life-saving drugs. Moreover, the rarity of these diseases results in a small patient population, which poses challenges for conducting large-scale clinical trials and hinders extensive data generation for long-term safety and efficacy. Another challenge is the complexity of disease diagnosis due to overlapping symptoms with other hematological or renal conditions, sometimes causing delayed or missed diagnosis. Lastly, the need for lifelong treatment in many cases raises concerns about patient adherence, potential side effects, and the development of resistance, necessitating continuous monitoring and management strategies.
This report is a detailed and comprehensive analysis for global PNH and aHUS market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global PNH and aHUS market size and forecasts, in consumption value ($ Million), 2021-2032
Global PNH and aHUS market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global PNH and aHUS market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global PNH and aHUS market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for PNH and aHUS
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global PNH and aHUS market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZeneca, Alexion Pharmaceutical, CJSC Generium, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
PNH and aHUS market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Soliris
- Ultomiris
- PNH
- aHUS
- AstraZeneca
- Alexion Pharmaceutical
- CJSC Generium
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe PNH and aHUS product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of PNH and aHUS, with revenue, gross margin, and global market share of PNH and aHUS from 2021 to 2026.
Chapter 3, the PNH and aHUS competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and PNH and aHUS market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of PNH and aHUS.
Chapter 13, to describe PNH and aHUS research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of PNH and aHUS by Type
1.3.1 Overview: Global PNH and aHUS Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global PNH and aHUS Consumption Value Market Share by Type in 2025
1.3.3 Soliris
1.3.4 Ultomiris
1.4 Global PNH and aHUS Market by Application
1.4.1 Overview: Global PNH and aHUS Market Size by Application: 2021 Versus 2025 Versus 2032
1.4.2 PNH
1.4.3 aHUS
1.5 Global PNH and aHUS Market Size & Forecast
1.6 Global PNH and aHUS Market Size and Forecast by Region
1.6.1 Global PNH and aHUS Market Size by Region: 2021 VS 2025 VS 2032
1.6.2 Global PNH and aHUS Market Size by Region, (2021-2032)
1.6.3 North America PNH and aHUS Market Size and Prospect (2021-2032)
1.6.4 Europe PNH and aHUS Market Size and Prospect (2021-2032)
1.6.5 Asia-Pacific PNH and aHUS Market Size and Prospect (2021-2032)
1.6.6 South America PNH and aHUS Market Size and Prospect (2021-2032)
1.6.7 Middle East & Africa PNH and aHUS Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca PNH and aHUS Product and Solutions
2.1.4 AstraZeneca PNH and aHUS Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 AstraZeneca Recent Developments and Future Plans
2.2 Alexion Pharmaceutical
2.2.1 Alexion Pharmaceutical Details
2.2.2 Alexion Pharmaceutical Major Business
2.2.3 Alexion Pharmaceutical PNH and aHUS Product and Solutions
2.2.4 Alexion Pharmaceutical PNH and aHUS Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Alexion Pharmaceutical Recent Developments and Future Plans
2.3 CJSC Generium
2.3.1 CJSC Generium Details
2.3.2 CJSC Generium Major Business
2.3.3 CJSC Generium PNH and aHUS Product and Solutions
2.3.4 CJSC Generium PNH and aHUS Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 CJSC Generium Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global PNH and aHUS Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of PNH and aHUS by Company Revenue
3.2.2 Top 3 PNH and aHUS Players Market Share in 2025
3.2.3 Top 6 PNH and aHUS Players Market Share in 2025
3.3 PNH and aHUS Market: Overall Company Footprint Analysis
3.3.1 PNH and aHUS Market: Region Footprint
3.3.2 PNH and aHUS Market: Company Product Type Footprint
3.3.3 PNH and aHUS Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global PNH and aHUS Consumption Value and Market Share by Type (2021-2026)
4.2 Global PNH and aHUS Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global PNH and aHUS Consumption Value Market Share by Application (2021-2026)
5.2 Global PNH and aHUS Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America PNH and aHUS Consumption Value by Type (2021-2032)
6.2 North America PNH and aHUS Market Size by Application (2021-2032)
6.3 North America PNH and aHUS Market Size by Country
6.3.1 North America PNH and aHUS Consumption Value by Country (2021-2032)
6.3.2 United States PNH and aHUS Market Size and Forecast (2021-2032)
6.3.3 Canada PNH and aHUS Market Size and Forecast (2021-2032)
6.3.4 Mexico PNH and aHUS Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe PNH and aHUS Consumption Value by Type (2021-2032)
7.2 Europe PNH and aHUS Consumption Value by Application (2021-2032)
7.3 Europe PNH and aHUS Market Size by Country
7.3.1 Europe PNH and aHUS Consumption Value by Country (2021-2032)
7.3.2 Germany PNH and aHUS Market Size and Forecast (2021-2032)
7.3.3 France PNH and aHUS Market Size and Forecast (2021-2032)
7.3.4 United Kingdom PNH and aHUS Market Size and Forecast (2021-2032)
7.3.5 Russia PNH and aHUS Market Size and Forecast (2021-2032)
7.3.6 Italy PNH and aHUS Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific PNH and aHUS Consumption Value by Type (2021-2032)
8.2 Asia-Pacific PNH and aHUS Consumption Value by Application (2021-2032)
8.3 Asia-Pacific PNH and aHUS Market Size by Region
8.3.1 Asia-Pacific PNH and aHUS Consumption Value by Region (2021-2032)
8.3.2 China PNH and aHUS Market Size and Forecast (2021-2032)
8.3.3 Japan PNH and aHUS Market Size and Forecast (2021-2032)
8.3.4 South Korea PNH and aHUS Market Size and Forecast (2021-2032)
8.3.5 India PNH and aHUS Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia PNH and aHUS Market Size and Forecast (2021-2032)
8.3.7 Australia PNH and aHUS Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America PNH and aHUS Consumption Value by Type (2021-2032)
9.2 South America PNH and aHUS Consumption Value by Application (2021-2032)
9.3 South America PNH and aHUS Market Size by Country
9.3.1 South America PNH and aHUS Consumption Value by Country (2021-2032)
9.3.2 Brazil PNH and aHUS Market Size and Forecast (2021-2032)
9.3.3 Argentina PNH and aHUS Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa PNH and aHUS Consumption Value by Type (2021-2032)
10.2 Middle East & Africa PNH and aHUS Consumption Value by Application (2021-2032)
10.3 Middle East & Africa PNH and aHUS Market Size by Country
10.3.1 Middle East & Africa PNH and aHUS Consumption Value by Country (2021-2032)
10.3.2 Turkey PNH and aHUS Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia PNH and aHUS Market Size and Forecast (2021-2032)
10.3.4 UAE PNH and aHUS Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 PNH and aHUS Market Drivers
11.2 PNH and aHUS Market Restraints
11.3 PNH and aHUS Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 PNH and aHUS Industry Chain
12.2 PNH and aHUS Upstream Analysis
12.3 PNH and aHUS Midstream Analysis
12.4 PNH and aHUS Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of PNH and aHUS by Type
1.3.1 Overview: Global PNH and aHUS Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global PNH and aHUS Consumption Value Market Share by Type in 2025
1.3.3 Soliris
1.3.4 Ultomiris
1.4 Global PNH and aHUS Market by Application
1.4.1 Overview: Global PNH and aHUS Market Size by Application: 2021 Versus 2025 Versus 2032
1.4.2 PNH
1.4.3 aHUS
1.5 Global PNH and aHUS Market Size & Forecast
1.6 Global PNH and aHUS Market Size and Forecast by Region
1.6.1 Global PNH and aHUS Market Size by Region: 2021 VS 2025 VS 2032
1.6.2 Global PNH and aHUS Market Size by Region, (2021-2032)
1.6.3 North America PNH and aHUS Market Size and Prospect (2021-2032)
1.6.4 Europe PNH and aHUS Market Size and Prospect (2021-2032)
1.6.5 Asia-Pacific PNH and aHUS Market Size and Prospect (2021-2032)
1.6.6 South America PNH and aHUS Market Size and Prospect (2021-2032)
1.6.7 Middle East & Africa PNH and aHUS Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca PNH and aHUS Product and Solutions
2.1.4 AstraZeneca PNH and aHUS Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 AstraZeneca Recent Developments and Future Plans
2.2 Alexion Pharmaceutical
2.2.1 Alexion Pharmaceutical Details
2.2.2 Alexion Pharmaceutical Major Business
2.2.3 Alexion Pharmaceutical PNH and aHUS Product and Solutions
2.2.4 Alexion Pharmaceutical PNH and aHUS Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Alexion Pharmaceutical Recent Developments and Future Plans
2.3 CJSC Generium
2.3.1 CJSC Generium Details
2.3.2 CJSC Generium Major Business
2.3.3 CJSC Generium PNH and aHUS Product and Solutions
2.3.4 CJSC Generium PNH and aHUS Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 CJSC Generium Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global PNH and aHUS Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of PNH and aHUS by Company Revenue
3.2.2 Top 3 PNH and aHUS Players Market Share in 2025
3.2.3 Top 6 PNH and aHUS Players Market Share in 2025
3.3 PNH and aHUS Market: Overall Company Footprint Analysis
3.3.1 PNH and aHUS Market: Region Footprint
3.3.2 PNH and aHUS Market: Company Product Type Footprint
3.3.3 PNH and aHUS Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global PNH and aHUS Consumption Value and Market Share by Type (2021-2026)
4.2 Global PNH and aHUS Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global PNH and aHUS Consumption Value Market Share by Application (2021-2026)
5.2 Global PNH and aHUS Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America PNH and aHUS Consumption Value by Type (2021-2032)
6.2 North America PNH and aHUS Market Size by Application (2021-2032)
6.3 North America PNH and aHUS Market Size by Country
6.3.1 North America PNH and aHUS Consumption Value by Country (2021-2032)
6.3.2 United States PNH and aHUS Market Size and Forecast (2021-2032)
6.3.3 Canada PNH and aHUS Market Size and Forecast (2021-2032)
6.3.4 Mexico PNH and aHUS Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe PNH and aHUS Consumption Value by Type (2021-2032)
7.2 Europe PNH and aHUS Consumption Value by Application (2021-2032)
7.3 Europe PNH and aHUS Market Size by Country
7.3.1 Europe PNH and aHUS Consumption Value by Country (2021-2032)
7.3.2 Germany PNH and aHUS Market Size and Forecast (2021-2032)
7.3.3 France PNH and aHUS Market Size and Forecast (2021-2032)
7.3.4 United Kingdom PNH and aHUS Market Size and Forecast (2021-2032)
7.3.5 Russia PNH and aHUS Market Size and Forecast (2021-2032)
7.3.6 Italy PNH and aHUS Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific PNH and aHUS Consumption Value by Type (2021-2032)
8.2 Asia-Pacific PNH and aHUS Consumption Value by Application (2021-2032)
8.3 Asia-Pacific PNH and aHUS Market Size by Region
8.3.1 Asia-Pacific PNH and aHUS Consumption Value by Region (2021-2032)
8.3.2 China PNH and aHUS Market Size and Forecast (2021-2032)
8.3.3 Japan PNH and aHUS Market Size and Forecast (2021-2032)
8.3.4 South Korea PNH and aHUS Market Size and Forecast (2021-2032)
8.3.5 India PNH and aHUS Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia PNH and aHUS Market Size and Forecast (2021-2032)
8.3.7 Australia PNH and aHUS Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America PNH and aHUS Consumption Value by Type (2021-2032)
9.2 South America PNH and aHUS Consumption Value by Application (2021-2032)
9.3 South America PNH and aHUS Market Size by Country
9.3.1 South America PNH and aHUS Consumption Value by Country (2021-2032)
9.3.2 Brazil PNH and aHUS Market Size and Forecast (2021-2032)
9.3.3 Argentina PNH and aHUS Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa PNH and aHUS Consumption Value by Type (2021-2032)
10.2 Middle East & Africa PNH and aHUS Consumption Value by Application (2021-2032)
10.3 Middle East & Africa PNH and aHUS Market Size by Country
10.3.1 Middle East & Africa PNH and aHUS Consumption Value by Country (2021-2032)
10.3.2 Turkey PNH and aHUS Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia PNH and aHUS Market Size and Forecast (2021-2032)
10.3.4 UAE PNH and aHUS Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 PNH and aHUS Market Drivers
11.2 PNH and aHUS Market Restraints
11.3 PNH and aHUS Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 PNH and aHUS Industry Chain
12.2 PNH and aHUS Upstream Analysis
12.3 PNH and aHUS Midstream Analysis
12.4 PNH and aHUS Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF FIGURES
Table 1. Global PNH and aHUS Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global PNH and aHUS Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Global PNH and aHUS Consumption Value by Region (2021-2026) & (USD Million)
Table 4. Global PNH and aHUS Consumption Value by Region (2027-2032) & (USD Million)
Table 5. AstraZeneca Company Information, Head Office, and Major Competitors
Table 6. AstraZeneca Major Business
Table 7. AstraZeneca PNH and aHUS Product and Solutions
Table 8. AstraZeneca PNH and aHUS Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. AstraZeneca Recent Developments and Future Plans
Table 10. Alexion Pharmaceutical Company Information, Head Office, and Major Competitors
Table 11. Alexion Pharmaceutical Major Business
Table 12. Alexion Pharmaceutical PNH and aHUS Product and Solutions
Table 13. Alexion Pharmaceutical PNH and aHUS Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Alexion Pharmaceutical Recent Developments and Future Plans
Table 15. CJSC Generium Company Information, Head Office, and Major Competitors
Table 16. CJSC Generium Major Business
Table 17. CJSC Generium PNH and aHUS Product and Solutions
Table 18. CJSC Generium PNH and aHUS Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. Global PNH and aHUS Revenue (USD Million) by Players (2021-2026)
Table 20. Global PNH and aHUS Revenue Share by Players (2021-2026)
Table 21. Breakdown of PNH and aHUS by Company Type (Tier 1, Tier 2, and Tier 3)
Table 22. Market Position of Players in PNH and aHUS, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 23. Head Office of Key PNH and aHUS Players
Table 24. PNH and aHUS Market: Company Product Type Footprint
Table 25. PNH and aHUS Market: Company Product Application Footprint
Table 26. PNH and aHUS New Market Entrants and Barriers to Market Entry
Table 27. PNH and aHUS Mergers, Acquisition, Agreements, and Collaborations
Table 28. Global PNH and aHUS Consumption Value (USD Million) by Type (2021-2026)
Table 29. Global PNH and aHUS Consumption Value Share by Type (2021-2026)
Table 30. Global PNH and aHUS Consumption Value Forecast by Type (2027-2032)
Table 31. Global PNH and aHUS Consumption Value by Application (2021-2026)
Table 32. Global PNH and aHUS Consumption Value Forecast by Application (2027-2032)
Table 33. North America PNH and aHUS Consumption Value by Type (2021-2026) & (USD Million)
Table 34. North America PNH and aHUS Consumption Value by Type (2027-2032) & (USD Million)
Table 35. North America PNH and aHUS Consumption Value by Application (2021-2026) & (USD Million)
Table 36. North America PNH and aHUS Consumption Value by Application (2027-2032) & (USD Million)
Table 37. North America PNH and aHUS Consumption Value by Country (2021-2026) & (USD Million)
Table 38. North America PNH and aHUS Consumption Value by Country (2027-2032) & (USD Million)
Table 39. Europe PNH and aHUS Consumption Value by Type (2021-2026) & (USD Million)
Table 40. Europe PNH and aHUS Consumption Value by Type (2027-2032) & (USD Million)
Table 41. Europe PNH and aHUS Consumption Value by Application (2021-2026) & (USD Million)
Table 42. Europe PNH and aHUS Consumption Value by Application (2027-2032) & (USD Million)
Table 43. Europe PNH and aHUS Consumption Value by Country (2021-2026) & (USD Million)
Table 44. Europe PNH and aHUS Consumption Value by Country (2027-2032) & (USD Million)
Table 45. Asia-Pacific PNH and aHUS Consumption Value by Type (2021-2026) & (USD Million)
Table 46. Asia-Pacific PNH and aHUS Consumption Value by Type (2027-2032) & (USD Million)
Table 47. Asia-Pacific PNH and aHUS Consumption Value by Application (2021-2026) & (USD Million)
Table 48. Asia-Pacific PNH and aHUS Consumption Value by Application (2027-2032) & (USD Million)
Table 49. Asia-Pacific PNH and aHUS Consumption Value by Region (2021-2026) & (USD Million)
Table 50. Asia-Pacific PNH and aHUS Consumption Value by Region (2027-2032) & (USD Million)
Table 51. South America PNH and aHUS Consumption Value by Type (2021-2026) & (USD Million)
Table 52. South America PNH and aHUS Consumption Value by Type (2027-2032) & (USD Million)
Table 53. South America PNH and aHUS Consumption Value by Application (2021-2026) & (USD Million)
Table 54. South America PNH and aHUS Consumption Value by Application (2027-2032) & (USD Million)
Table 55. South America PNH and aHUS Consumption Value by Country (2021-2026) & (USD Million)
Table 56. South America PNH and aHUS Consumption Value by Country (2027-2032) & (USD Million)
Table 57. Middle East & Africa PNH and aHUS Consumption Value by Type (2021-2026) & (USD Million)
Table 58. Middle East & Africa PNH and aHUS Consumption Value by Type (2027-2032) & (USD Million)
Table 59. Middle East & Africa PNH and aHUS Consumption Value by Application (2021-2026) & (USD Million)
Table 60. Middle East & Africa PNH and aHUS Consumption Value by Application (2027-2032) & (USD Million)
Table 61. Middle East & Africa PNH and aHUS Consumption Value by Country (2021-2026) & (USD Million)
Table 62. Middle East & Africa PNH and aHUS Consumption Value by Country (2027-2032) & (USD Million)
Table 63. Global Key Players of PNH and aHUS Upstream (Raw Materials)
Table 64. Global PNH and aHUS Typical Customers
LIST OF FIGURES
Figure 1. PNH and aHUS Picture
Figure 2. Global PNH and aHUS Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global PNH and aHUS Consumption Value Market Share by Type in 2025
Figure 4. Soliris
Figure 5. Ultomiris
Figure 6. Global PNH and aHUS Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 7. PNH and aHUS Consumption Value Market Share by Application in 2025
Figure 8. PNH Picture
Figure 9. aHUS Picture
Figure 10. Global PNH and aHUS Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 11. Global PNH and aHUS Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 12. Global Market PNH and aHUS Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 13. Global PNH and aHUS Consumption Value Market Share by Region (2021-2032)
Figure 14. Global PNH and aHUS Consumption Value Market Share by Region in 2025
Figure 15. North America PNH and aHUS Consumption Value (2021-2032) & (USD Million)
Figure 16. Europe PNH and aHUS Consumption Value (2021-2032) & (USD Million)
Figure 17. Asia-Pacific PNH and aHUS Consumption Value (2021-2032) & (USD Million)
Figure 18. South America PNH and aHUS Consumption Value (2021-2032) & (USD Million)
Figure 19. Middle East & Africa PNH and aHUS Consumption Value (2021-2032) & (USD Million)
Figure 20. Company Three Recent Developments and Future Plans
Figure 21. Global PNH and aHUS Revenue Share by Players in 2025
Figure 22. PNH and aHUS Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 23. Market Share of PNH and aHUS by Player Revenue in 2025
Figure 24. Top 3 PNH and aHUS Players Market Share in 2025
Figure 25. Top 6 PNH and aHUS Players Market Share in 2025
Figure 26. Global PNH and aHUS Consumption Value Share by Type (2021-2026)
Figure 27. Global PNH and aHUS Market Share Forecast by Type (2027-2032)
Figure 28. Global PNH and aHUS Consumption Value Share by Application (2021-2026)
Figure 29. Global PNH and aHUS Market Share Forecast by Application (2027-2032)
Figure 30. North America PNH and aHUS Consumption Value Market Share by Type (2021-2032)
Figure 31. North America PNH and aHUS Consumption Value Market Share by Application (2021-2032)
Figure 32. North America PNH and aHUS Consumption Value Market Share by Country (2021-2032)
Figure 33. United States PNH and aHUS Consumption Value (2021-2032) & (USD Million)
Figure 34. Canada PNH and aHUS Consumption Value (2021-2032) & (USD Million)
Figure 35. Mexico PNH and aHUS Consumption Value (2021-2032) & (USD Million)
Figure 36. Europe PNH and aHUS Consumption Value Market Share by Type (2021-2032)
Figure 37. Europe PNH and aHUS Consumption Value Market Share by Application (2021-2032)
Figure 38. Europe PNH and aHUS Consumption Value Market Share by Country (2021-2032)
Figure 39. Germany PNH and aHUS Consumption Value (2021-2032) & (USD Million)
Figure 40. France PNH and aHUS Consumption Value (2021-2032) & (USD Million)
Figure 41. United Kingdom PNH and aHUS Consumption Value (2021-2032) & (USD Million)
Figure 42. Russia PNH and aHUS Consumption Value (2021-2032) & (USD Million)
Figure 43. Italy PNH and aHUS Consumption Value (2021-2032) & (USD Million)
Figure 44. Asia-Pacific PNH and aHUS Consumption Value Market Share by Type (2021-2032)
Figure 45. Asia-Pacific PNH and aHUS Consumption Value Market Share by Application (2021-2032)
Figure 46. Asia-Pacific PNH and aHUS Consumption Value Market Share by Region (2021-2032)
Figure 47. China PNH and aHUS Consumption Value (2021-2032) & (USD Million)
Figure 48. Japan PNH and aHUS Consumption Value (2021-2032) & (USD Million)
Figure 49. South Korea PNH and aHUS Consumption Value (2021-2032) & (USD Million)
Figure 50. India PNH and aHUS Consumption Value (2021-2032) & (USD Million)
Figure 51. Southeast Asia PNH and aHUS Consumption Value (2021-2032) & (USD Million)
Figure 52. Australia PNH and aHUS Consumption Value (2021-2032) & (USD Million)
Figure 53. South America PNH and aHUS Consumption Value Market Share by Type (2021-2032)
Figure 54. South America PNH and aHUS Consumption Value Market Share by Application (2021-2032)
Figure 55. South America PNH and aHUS Consumption Value Market Share by Country (2021-2032)
Figure 56. Brazil PNH and aHUS Consumption Value (2021-2032) & (USD Million)
Figure 57. Argentina PNH and aHUS Consumption Value (2021-2032) & (USD Million)
Figure 58. Middle East & Africa PNH and aHUS Consumption Value Market Share by Type (2021-2032)
Figure 59. Middle East & Africa PNH and aHUS Consumption Value Market Share by Application (2021-2032)
Figure 60. Middle East & Africa PNH and aHUS Consumption Value Market Share by Country (2021-2032)
Figure 61. Turkey PNH and aHUS Consumption Value (2021-2032) & (USD Million)
Figure 62. Saudi Arabia PNH and aHUS Consumption Value (2021-2032) & (USD Million)
Figure 63. UAE PNH and aHUS Consumption Value (2021-2032) & (USD Million)
Figure 64. PNH and aHUS Market Drivers
Figure 65. PNH and aHUS Market Restraints
Figure 66. PNH and aHUS Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. PNH and aHUS Industrial Chain
Figure 69. Methodology
Figure 70. Research Process and Data Source
Table 1. Global PNH and aHUS Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global PNH and aHUS Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Global PNH and aHUS Consumption Value by Region (2021-2026) & (USD Million)
Table 4. Global PNH and aHUS Consumption Value by Region (2027-2032) & (USD Million)
Table 5. AstraZeneca Company Information, Head Office, and Major Competitors
Table 6. AstraZeneca Major Business
Table 7. AstraZeneca PNH and aHUS Product and Solutions
Table 8. AstraZeneca PNH and aHUS Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. AstraZeneca Recent Developments and Future Plans
Table 10. Alexion Pharmaceutical Company Information, Head Office, and Major Competitors
Table 11. Alexion Pharmaceutical Major Business
Table 12. Alexion Pharmaceutical PNH and aHUS Product and Solutions
Table 13. Alexion Pharmaceutical PNH and aHUS Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Alexion Pharmaceutical Recent Developments and Future Plans
Table 15. CJSC Generium Company Information, Head Office, and Major Competitors
Table 16. CJSC Generium Major Business
Table 17. CJSC Generium PNH and aHUS Product and Solutions
Table 18. CJSC Generium PNH and aHUS Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. Global PNH and aHUS Revenue (USD Million) by Players (2021-2026)
Table 20. Global PNH and aHUS Revenue Share by Players (2021-2026)
Table 21. Breakdown of PNH and aHUS by Company Type (Tier 1, Tier 2, and Tier 3)
Table 22. Market Position of Players in PNH and aHUS, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 23. Head Office of Key PNH and aHUS Players
Table 24. PNH and aHUS Market: Company Product Type Footprint
Table 25. PNH and aHUS Market: Company Product Application Footprint
Table 26. PNH and aHUS New Market Entrants and Barriers to Market Entry
Table 27. PNH and aHUS Mergers, Acquisition, Agreements, and Collaborations
Table 28. Global PNH and aHUS Consumption Value (USD Million) by Type (2021-2026)
Table 29. Global PNH and aHUS Consumption Value Share by Type (2021-2026)
Table 30. Global PNH and aHUS Consumption Value Forecast by Type (2027-2032)
Table 31. Global PNH and aHUS Consumption Value by Application (2021-2026)
Table 32. Global PNH and aHUS Consumption Value Forecast by Application (2027-2032)
Table 33. North America PNH and aHUS Consumption Value by Type (2021-2026) & (USD Million)
Table 34. North America PNH and aHUS Consumption Value by Type (2027-2032) & (USD Million)
Table 35. North America PNH and aHUS Consumption Value by Application (2021-2026) & (USD Million)
Table 36. North America PNH and aHUS Consumption Value by Application (2027-2032) & (USD Million)
Table 37. North America PNH and aHUS Consumption Value by Country (2021-2026) & (USD Million)
Table 38. North America PNH and aHUS Consumption Value by Country (2027-2032) & (USD Million)
Table 39. Europe PNH and aHUS Consumption Value by Type (2021-2026) & (USD Million)
Table 40. Europe PNH and aHUS Consumption Value by Type (2027-2032) & (USD Million)
Table 41. Europe PNH and aHUS Consumption Value by Application (2021-2026) & (USD Million)
Table 42. Europe PNH and aHUS Consumption Value by Application (2027-2032) & (USD Million)
Table 43. Europe PNH and aHUS Consumption Value by Country (2021-2026) & (USD Million)
Table 44. Europe PNH and aHUS Consumption Value by Country (2027-2032) & (USD Million)
Table 45. Asia-Pacific PNH and aHUS Consumption Value by Type (2021-2026) & (USD Million)
Table 46. Asia-Pacific PNH and aHUS Consumption Value by Type (2027-2032) & (USD Million)
Table 47. Asia-Pacific PNH and aHUS Consumption Value by Application (2021-2026) & (USD Million)
Table 48. Asia-Pacific PNH and aHUS Consumption Value by Application (2027-2032) & (USD Million)
Table 49. Asia-Pacific PNH and aHUS Consumption Value by Region (2021-2026) & (USD Million)
Table 50. Asia-Pacific PNH and aHUS Consumption Value by Region (2027-2032) & (USD Million)
Table 51. South America PNH and aHUS Consumption Value by Type (2021-2026) & (USD Million)
Table 52. South America PNH and aHUS Consumption Value by Type (2027-2032) & (USD Million)
Table 53. South America PNH and aHUS Consumption Value by Application (2021-2026) & (USD Million)
Table 54. South America PNH and aHUS Consumption Value by Application (2027-2032) & (USD Million)
Table 55. South America PNH and aHUS Consumption Value by Country (2021-2026) & (USD Million)
Table 56. South America PNH and aHUS Consumption Value by Country (2027-2032) & (USD Million)
Table 57. Middle East & Africa PNH and aHUS Consumption Value by Type (2021-2026) & (USD Million)
Table 58. Middle East & Africa PNH and aHUS Consumption Value by Type (2027-2032) & (USD Million)
Table 59. Middle East & Africa PNH and aHUS Consumption Value by Application (2021-2026) & (USD Million)
Table 60. Middle East & Africa PNH and aHUS Consumption Value by Application (2027-2032) & (USD Million)
Table 61. Middle East & Africa PNH and aHUS Consumption Value by Country (2021-2026) & (USD Million)
Table 62. Middle East & Africa PNH and aHUS Consumption Value by Country (2027-2032) & (USD Million)
Table 63. Global Key Players of PNH and aHUS Upstream (Raw Materials)
Table 64. Global PNH and aHUS Typical Customers
LIST OF FIGURES
Figure 1. PNH and aHUS Picture
Figure 2. Global PNH and aHUS Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global PNH and aHUS Consumption Value Market Share by Type in 2025
Figure 4. Soliris
Figure 5. Ultomiris
Figure 6. Global PNH and aHUS Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 7. PNH and aHUS Consumption Value Market Share by Application in 2025
Figure 8. PNH Picture
Figure 9. aHUS Picture
Figure 10. Global PNH and aHUS Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 11. Global PNH and aHUS Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 12. Global Market PNH and aHUS Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 13. Global PNH and aHUS Consumption Value Market Share by Region (2021-2032)
Figure 14. Global PNH and aHUS Consumption Value Market Share by Region in 2025
Figure 15. North America PNH and aHUS Consumption Value (2021-2032) & (USD Million)
Figure 16. Europe PNH and aHUS Consumption Value (2021-2032) & (USD Million)
Figure 17. Asia-Pacific PNH and aHUS Consumption Value (2021-2032) & (USD Million)
Figure 18. South America PNH and aHUS Consumption Value (2021-2032) & (USD Million)
Figure 19. Middle East & Africa PNH and aHUS Consumption Value (2021-2032) & (USD Million)
Figure 20. Company Three Recent Developments and Future Plans
Figure 21. Global PNH and aHUS Revenue Share by Players in 2025
Figure 22. PNH and aHUS Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 23. Market Share of PNH and aHUS by Player Revenue in 2025
Figure 24. Top 3 PNH and aHUS Players Market Share in 2025
Figure 25. Top 6 PNH and aHUS Players Market Share in 2025
Figure 26. Global PNH and aHUS Consumption Value Share by Type (2021-2026)
Figure 27. Global PNH and aHUS Market Share Forecast by Type (2027-2032)
Figure 28. Global PNH and aHUS Consumption Value Share by Application (2021-2026)
Figure 29. Global PNH and aHUS Market Share Forecast by Application (2027-2032)
Figure 30. North America PNH and aHUS Consumption Value Market Share by Type (2021-2032)
Figure 31. North America PNH and aHUS Consumption Value Market Share by Application (2021-2032)
Figure 32. North America PNH and aHUS Consumption Value Market Share by Country (2021-2032)
Figure 33. United States PNH and aHUS Consumption Value (2021-2032) & (USD Million)
Figure 34. Canada PNH and aHUS Consumption Value (2021-2032) & (USD Million)
Figure 35. Mexico PNH and aHUS Consumption Value (2021-2032) & (USD Million)
Figure 36. Europe PNH and aHUS Consumption Value Market Share by Type (2021-2032)
Figure 37. Europe PNH and aHUS Consumption Value Market Share by Application (2021-2032)
Figure 38. Europe PNH and aHUS Consumption Value Market Share by Country (2021-2032)
Figure 39. Germany PNH and aHUS Consumption Value (2021-2032) & (USD Million)
Figure 40. France PNH and aHUS Consumption Value (2021-2032) & (USD Million)
Figure 41. United Kingdom PNH and aHUS Consumption Value (2021-2032) & (USD Million)
Figure 42. Russia PNH and aHUS Consumption Value (2021-2032) & (USD Million)
Figure 43. Italy PNH and aHUS Consumption Value (2021-2032) & (USD Million)
Figure 44. Asia-Pacific PNH and aHUS Consumption Value Market Share by Type (2021-2032)
Figure 45. Asia-Pacific PNH and aHUS Consumption Value Market Share by Application (2021-2032)
Figure 46. Asia-Pacific PNH and aHUS Consumption Value Market Share by Region (2021-2032)
Figure 47. China PNH and aHUS Consumption Value (2021-2032) & (USD Million)
Figure 48. Japan PNH and aHUS Consumption Value (2021-2032) & (USD Million)
Figure 49. South Korea PNH and aHUS Consumption Value (2021-2032) & (USD Million)
Figure 50. India PNH and aHUS Consumption Value (2021-2032) & (USD Million)
Figure 51. Southeast Asia PNH and aHUS Consumption Value (2021-2032) & (USD Million)
Figure 52. Australia PNH and aHUS Consumption Value (2021-2032) & (USD Million)
Figure 53. South America PNH and aHUS Consumption Value Market Share by Type (2021-2032)
Figure 54. South America PNH and aHUS Consumption Value Market Share by Application (2021-2032)
Figure 55. South America PNH and aHUS Consumption Value Market Share by Country (2021-2032)
Figure 56. Brazil PNH and aHUS Consumption Value (2021-2032) & (USD Million)
Figure 57. Argentina PNH and aHUS Consumption Value (2021-2032) & (USD Million)
Figure 58. Middle East & Africa PNH and aHUS Consumption Value Market Share by Type (2021-2032)
Figure 59. Middle East & Africa PNH and aHUS Consumption Value Market Share by Application (2021-2032)
Figure 60. Middle East & Africa PNH and aHUS Consumption Value Market Share by Country (2021-2032)
Figure 61. Turkey PNH and aHUS Consumption Value (2021-2032) & (USD Million)
Figure 62. Saudi Arabia PNH and aHUS Consumption Value (2021-2032) & (USD Million)
Figure 63. UAE PNH and aHUS Consumption Value (2021-2032) & (USD Million)
Figure 64. PNH and aHUS Market Drivers
Figure 65. PNH and aHUS Market Restraints
Figure 66. PNH and aHUS Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. PNH and aHUS Industrial Chain
Figure 69. Methodology
Figure 70. Research Process and Data Source
